bilirubin oxidase (Kumamoto)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebilirubin oxidase (Kumamoto)
Drug Alias Namebilirubin oxidase
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsHyperbilirubinemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKumamoto University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKumamoto University
Active IndicationsN/A
Inactive IndicationsHyperbilirubinemia

Other Information

ATC CodeN/A
Related LinksN/A